Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Cell Counting Kit-8 (CCK-8): Sensitive Cell Viability and...

    2025-11-21

    Cell Counting Kit-8 (CCK-8): Sensitive Cell Viability and Proliferation Assays with WST-8

    Executive Summary: The Cell Counting Kit-8 (CCK-8) is a widely used, water-soluble tetrazolium salt-based assay that quantifies cellular metabolic activity via WST-8 reduction, directly correlating with cell viability and proliferation (Liu et al., 2022). It is more sensitive and operationally simpler than MTT, XTT, MTS, or WST-1 assays (internal review). The readout is highly reproducible and suitable for high-throughput screening. CCK-8 is extensively applied in cancer research, neurodegeneration, and cytotoxicity workflows. The kit is supplied by APExBIO (SKU: K1018).

    Biological Rationale

    Cell viability and proliferation assays are fundamental for evaluating cytotoxicity, drug efficacy, and disease modeling. In neurodegenerative disorders such as Parkinson’s disease (PD), selective loss of dopaminergic neurons is a key pathological feature (Liu et al., 2022). Reliable quantification of living cells is essential for mechanistic studies in such contexts. The Cell Counting Kit-8 (CCK-8) enables researchers to measure cell viability in response to genetic, pharmacological, or environmental perturbations. This is crucial for assays involving mitochondrial dysfunction, oxidative stress, or apoptosis. WST-8-based detection is compatible with a variety of cell types, including primary neurons, cancer cell lines, and stem cells (internal review).

    Mechanism of Action of Cell Counting Kit-8 (CCK-8)

    CCK-8 employs WST-8, a water-soluble tetrazolium salt, as the detection reagent. In metabolically active cells, intracellular dehydrogenases reduce WST-8 to produce a water-soluble formazan dye. The amount of formazan is directly proportional to the number of viable cells. The reaction occurs in the presence of an electron mediator (1-methoxy PMS) and does not require solubilization steps, unlike the MTT assay. The formazan's absorbance is measured at 450 nm using a microplate reader. This enables real-time, non-radioactive quantification of cell proliferation and viability (internal review; mechanistic advances).

    Evidence & Benchmarks

    • CCK-8 detects cell viability changes with higher sensitivity than MTT and WST-1 assays, as shown in comparative studies of dopaminergic neuron damage in PD models (DOI:10.1038/s41419-022-04934-2).
    • Formazan product is water-soluble, eliminating the need for additional solubilization, thus reducing hands-on time and variability (APExBIO product page).
    • CCK-8 is compatible with high-throughput screening and multiwell plate formats due to its non-toxic and rapid protocol (internal review).
    • In PD models, CCK-8 was used to quantify dopaminergic neuron viability following rotenone-induced toxicity, correlating with TH-positive cell counts and behavioral outcomes (DOI:10.1038/s41419-022-04934-2).
    • CCK-8 enables assessment of cytotoxicity in cancer and aging research, outperforming legacy tetrazolium-based methods (mechanistic advances).

    Applications, Limits & Misconceptions

    Applications:

    • Cell proliferation and cytotoxicity assessment in cancer research, enabling drug screening and mechanistic studies (internal review).
    • Viability measurement in neurodegenerative disease models, such as quantification of dopaminergic neuron survival in Parkinson’s disease (Liu et al., 2022).
    • Evaluation of stem cell proliferation and differentiation, providing a non-destructive readout for regenerative medicine (stem cell research).
    • Workflow integration in high-throughput drug screening, enabled by single-step, non-toxic protocols.

    Limits & Common Pitfalls or Misconceptions

    Common Pitfalls or Misconceptions

    • CCK-8 measures metabolic activity, not direct cell count; quiescent but viable cells may be underestimated.
    • Some compounds may interfere with dehydrogenase activity or the tetrazolium reduction, leading to false signals (mechanistic advances).
    • The assay is not suitable for non-adherent cells without optimization, as washing steps may remove viable cells.
    • High cell densities can exceed the linear range of detection, necessitating titration and standard curve establishment.
    • CCK-8 is not a substitute for apoptosis-specific or necrosis-specific assays; it only reflects general cell viability.

    This article extends prior reviews (internal review) by providing updated benchmarks from recent neurodegeneration studies and clarifies boundaries in data interpretation not covered in stem cell-focused applications.

    Workflow Integration & Parameters

    For optimal results with the Cell Counting Kit-8 (CCK-8), adhere to the following parameters:

    • Use a seeding density that maintains cell proliferation within the linear range of the assay (typically 2,000–10,000 cells/well for 96-well plates).
    • Add 10 μL of CCK-8 reagent per 100 μL culture medium; incubate at 37°C for 1–4 hours, monitoring absorbance at 450 nm.
    • For cytotoxicity assays, include appropriate untreated and vehicle controls.
    • Normalize absorbance values to blank wells containing medium and reagent only.

    The kit (SKU: K1018) is compatible with automation and robotic platforms. Data are exportable for downstream statistical analysis. Detailed protocols are provided by APExBIO.

    Conclusion & Outlook

    The Cell Counting Kit-8 (CCK-8) is a sensitive, reliable, and user-friendly tool for measuring cell viability and proliferation in a broad range of experimental systems. Its WST-8 chemistry surpasses traditional tetrazolium-based assays in sensitivity and convenience. CCK-8's robust performance in disease modeling, especially neurodegeneration and cancer, has been validated in multiple peer-reviewed studies (Liu et al., 2022). As research demands increase for high-throughput and reproducible viability assays, CCK-8 is positioned as a gold standard, particularly in workflows where accuracy and simplicity are critical. For further reading on mechanistic advances, see From Mechanism to Impact: Strategic Advances in Translational Research, which complements this update by dissecting the molecular underpinnings and translational potential of WST-8-based cell viability measurement.